Tiroiditis posparto en Uruguay

Erica Balaguer Teske; Beatriz Masena Rodríguez; Francisco Cóppola Gonzálvez; Claudio Sosa Fuertes; Juan Carlos Silvera

Authors

Erica Balaguer Teske Centro Hospitalario Pereira Rossell, Jefa de Residentes de Ginecotocología. Clínica Ginecotocológica "A", Prof. Dr. Pons., Ginecotocología, Ex Asistente
Beatriz Masena Rodríguez Centro Hospitalario Pereira Rossell, Clínica Ginecotocológica "A", Prof. Dr. Pons, Ex Residente. Ginecotocóloga
Francisco Cóppola Gonzálvez Centro Hospitalario Pereira Rossell, Clínica Ginecotocológica "C", Prof. Dr. Alonso, Profesor Adjunto
Claudio Sosa Fuertes Centro Hospitalario Pereira Rossell, Clínica Ginecotocológica "C", Prof. Dr. Alonso, Profesor Adjunto
Juan Carlos Silvera Centro Hospitalario Pereira Rossell, Laboratorio Central, Sector Hormonas, Sección Bioquímica, Encargado. Médico Laboratorista

Keywords:

POSTPARTUM THYROIDITIS, AUTOIMMUNE THYROIDITIS

Abstract

Postpartum tiroiditis is a syndrome of thyroid dysfunction permanent or transitory that occurs after childbirth. There is no data on the prevalence of postpartum thyroidism in Uruguay.
Objective: to asses prevalence of postpartum thyroi-dism in a cohort of women, users of Public Health Services.
Methods: a descriptive observational study of 105 women who had given birth in the previous 9 months was performed. Women with already known thyroid disease were excluded.
All women were treated with thyrotropine; at month three women with pathology received an extra dose o thyrotropine and antithyroperoxidase antibodies.
Results: postpartum thyroidism was found in 5,7%, non-associated hypothyroidism with thyroidism in 6.7% (12,4% total). Pathologic associated symptoms rate was no significant (x2=0,431). The curve of TSH normal values was determinated considering postpartum months.
Conclusions: the concept of postpartum thyroidism as a mild and temporal desorder is changing, it is currently recognized as an acute fase of a chronic autoimmune thyroiditis process with negative sequelae for both mother and child. Wideworld prevalence is 1,1% to 21%; our population showed 5,7% women with the disease and total pathologic findings in 12,4% women, non-associated with clinical symtomps.
The prevalence of this affection may necessary to assess and design adequate screening tools.

References

(1) Muller A, Drexhage H, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001; 22(5): 605-30.
(2) Roti E, Degli Uberti E. Post-partum thyroiditis- a clinical update. Eur J Endocrinol 2002; 146: 275-9. Disponible en: http://www.eje.org/cgi/reprint/146/3/275. (Consulta: ago 2005).
(3) Olivieri S, De Angelis S, Vaccari V, Valensise H, Magnani F, Stazi MA, et al. Postpartum thyroiditis is associated with fluctuations in transforming growth factor-â1 serum levels. J Clin Endocrinol Metab 2003; 88(3): 1280-4. Disponible en: http://jcem.endojournals.org/cgi/reprint/88/3/1280. (Consulta: 9 may 2005).
(4) Lazarus JH. Thyroid dysfunction: reproduction and postpartum thyroiditis. Semin Reprod Med 2002; 20(4): 381-8. Disponible en: www.ncbi.nlm.nih.gov. (Consulta: abril 2005)
(5) Stagnaro-Green A. Clinical review 152: postpartum thyroiditis. J Clin Endocrinol Metab 2002; 87(9): 4042-7. Disponible en: http://jcem.endojournals.org/cgi/reprint/87/9/4042. (Consulta: 9 may 2005).
(6) Speroff L, Glass R, Kase N. Reproducción y tiroides. In: Speroff L, Glass R, Kase N, eds Endocrinología ginecológica e infertilidad. Barcelona: Waverly Hispánica, 2000: 809-28.
(7) Lazarus Jh, Parkes Ab, Premawardhana LD. Postpartum Thyroiditis. Autoimmunity 2002; 35(3): 169-73. Disponible en: www.ncbi.nlm.nih.gov. (Consulta: abril 2005)
(8) Amino N, Tada H, Hidaka Y, Crapo L, Stagnaro-Green A. Therapeutic controversy: screening for postpartum thyroiditis. J Clin Endocrinol Metab 1999; 84(6): 1813-21. Disponible en: http://jcem.endojournals.org/cgi/reprint/84/6/1813. (Consulta: 9 may 2005).